Sotera Health (NASDAQ:SHC - Get Free Report) shares saw strong trading volume on Tuesday . 1,561,190 shares were traded during trading, an increase of 33% from the previous session's volume of 1,171,206 shares.The stock last traded at $11.36 and had previously closed at $11.66.
Analysts Set New Price Targets
Separately, Barclays lowered their price objective on shares of Sotera Health from $17.00 to $16.00 and set an "overweight" rating on the stock in a research report on Friday, February 28th. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $16.00.
View Our Latest Research Report on SHC
Sotera Health Trading Down 3.6 %
The firm has a market capitalization of $2.93 billion, a price-to-earnings ratio of 41.36 and a beta of 1.88. The company has a fifty day moving average price of $12.61 and a 200-day moving average price of $13.80. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently modified their holdings of the business. Xponance Inc. increased its position in Sotera Health by 6.0% during the fourth quarter. Xponance Inc. now owns 17,495 shares of the company's stock worth $239,000 after buying an additional 989 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its stake in shares of Sotera Health by 2.1% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 51,940 shares of the company's stock worth $711,000 after acquiring an additional 1,047 shares in the last quarter. GAMMA Investing LLC raised its stake in shares of Sotera Health by 37.5% in the 4th quarter. GAMMA Investing LLC now owns 4,109 shares of the company's stock valued at $56,000 after acquiring an additional 1,121 shares in the last quarter. Blue Trust Inc. lifted its holdings in Sotera Health by 164.3% in the 4th quarter. Blue Trust Inc. now owns 1,834 shares of the company's stock worth $25,000 after purchasing an additional 1,140 shares during the last quarter. Finally, Tower Research Capital LLC TRC lifted its holdings in Sotera Health by 37.8% in the 4th quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company's stock worth $82,000 after purchasing an additional 1,640 shares during the last quarter. Institutional investors own 91.03% of the company's stock.
Sotera Health Company Profile
(
Get Free Report)
Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.
See Also
Before you consider Sotera Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sotera Health wasn't on the list.
While Sotera Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.